Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    Open Studies | "Coronavirus Infections"
Show Display Options
Rank Status Study
1 Recruiting MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
Condition: Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Interventions: Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b;   Drug: Placebo
2 Recruiting Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults
Condition: Middle East Respiratory Syndrome Coronavirus
Interventions: Biological: SAB-301;   Other: Normal (9%) Saline
3 Recruiting Respiratory Virus Hospitalization Study (FLU 003 Plus)
Conditions: Influenza;   Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV);   Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Intervention:

Study has passed its completion date and status has not been verified in more than two years.